Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.
Research Base: Children's Oncology Group
NCT ID: NCT01790152
NCI Protocol Number: COG-ALTE11C2
Status: Recruiting
For more information see ClinicalTrials.gov
Interventions
- Assessment of Therapy Complications
- Laboratory Biomarker Analysis
- Quality-of-Life Assessment
- Questionnaire Administration
Condition
Hodgkin Lymphoma in Remission, Leukemia in Remission, Lymphoblastic Lymphoma, Osteosarcoma, Recurrent Leukemia, Recurrent Lymphoma, Recurrent Malignant Neoplasm
Trial Type
Other
See a list of participating sites on ClinicalTrials.gov